iSAM Funds (UK)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-42,062
Closed -$2.27M 311
2025
Q4
$2.27M Sell
42,062
-10,192
-20% -$490K 0.82% 31
2025
Q3
$2.36M Buy
+52,254
New +$2.44M 0.48% 51
2024
Q4
Sell
-6,469
Closed -$335K 263
2024
Q3
$335K Sell
6,469
-1,061
-14% -$49.8K 0.19% 198
2024
Q2
$313K Buy
+7,530
New +$337K 0.23% 160
2023
Q4
Sell
-14,547
Closed -$844K 217
2023
Q3
$844K Buy
+14,547
New +$891K 0.53% 65
2023
Q1
Sell
-2,890
Closed -$208K 160
2022
Q4
$208K Buy
+2,890
New +$218K 0.62% 81

Other funds holding BMY

iSAM Funds (UK)'s BMY Position: Q1 2026 in Review

iSAM Funds (UK) sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 42,062 shares — an estimated $2.27M sold.

iSAM Funds (UK) first reported a position in BMY in Q4 2022 and held it in 6 quarters. The position peaked at $2.36M in Q3 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • iSAM Funds (UK) reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • iSAM Funds (UK) sold 42,062 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.27M.
  • iSAM Funds (UK) first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 6 quarters.
  • iSAM Funds (UK)'s Bristol-Myers Squibb position peaked at $2.36M in Q3 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on iSAM Funds (UK)'s 13F filing for Q1 2026, filed 13 May 2026.